Retour
Fourchette du Jour
26,98 €
28,30 €
Fourchette 52 Semaines
7,73 €
42,27 €
Volume
189 345
Moyenne 50J / 200J
28,03 €
/
23,20 €
Clôture Précédente
27,91 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,3 | 0,4 |
| P/B | 2,1 | 2,9 |
| ROE % | -28,2 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
43,33 €
+53.4%
Low: 40,00 €
High: 47,00 €
BPA Prévisionnel
-3,36 €
CA Est.
13 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-3,58 €
-3,58 € – -3,58 €
|
66 M | 1 |
| FY2029 |
-4,74 €
-4,74 € – -4,74 €
|
30 M | 1 |
| FY2028 |
-4,77 €
-5,47 € – -3,28 €
|
0 | 5 |
Points Clés
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -88,09M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-28,22%
ROIC-18,91%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,02
Current Ratio26,17
Interest Coverage0,00
Valorisation
P/E Ratio
-9,25
P/B Ratio2,13
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -111,48M |
| ROE | -28,22% | ROA | -21,76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -88,09M |
| ROIC | -18,91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 26,17 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,25 | P/B Ratio | 2,13 |
| P/S Ratio | N/A | PEG Ratio | -0,02 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,03B | Enterprise Value | 989,90M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -111,48M | -78,31M | -34,79M | -10,65M |
| EPS (Diluted) | -2,86 | -0,38 | -0,19 | -0,05 |
| Gross Profit | -1,02M | -839 000,0 | -112 000,0 | -15 000,0 |
| Operating Income | -125,10M | -83,06M | -36,18M | -10,37M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 512,43M | 314,93M | 155,42M | 31,60M |
| Total Liabilities | 27,78M | 9,51M | 181,06M | 12,10M |
| Shareholders' Equity | 484,65M | 305,43M | -25,63M | 19,51M |
| Total Debt | 11,48M | 1,48M | 2,15M | 10,44M |
| Cash & Equivalents | 52,65M | 56,81M | 70,17M | 31,16M |
| Current Assets | 498,56M | 309,80M | 150,87M | 31,27M |
| Current Liabilities | 19,05M | 8,77M | 8,80M | 1,66M |